JOHN A FLORENO

Allopathic & Osteopathic Physicians|Family Medicine WARREN, MI NPI 1104800481

General Payments — all program years on this page

$3,313.12

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 212
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $454.68 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $454.6821

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $737.4054
2019 $820.2161
2020 $91.997
2021 $274.2115
2022 $327.9519
2023 $606.6835
2024 $454.6821

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096653967 Novo Nordisk Inc $14.67 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096951337 Novo Nordisk Inc $18.39 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097052497 Novo Nordisk Inc $16.14 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097429433 Novo Nordisk Inc $13.33 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097670496 Novo Nordisk Inc $16.60 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103737417 ABBVIE INC. $18.24 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103737419 ABBVIE INC. $15.20 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104486132 AstraZeneca Pharmaceuticals LP $16.50 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104621744 AstraZeneca Pharmaceuticals LP $107.10 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105457774 AstraZeneca Pharmaceuticals LP $16.45 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114659115 Exact Sciences Corporation $21.50 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116478477 GlaxoSmithKline, LLC. $14.40 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117251834 Amgen Inc. $15.06 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117251836 Amgen Inc. $16.87 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117874155 Boehringer Ingelheim Pharmaceuticals, Inc. $21.38 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117874157 Boehringer Ingelheim Pharmaceuticals, Inc. $26.56 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131085059 PFIZER INC. $15.94 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131488639 PFIZER INC. $15.44 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135053364 Lilly USA, LLC $13.64 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135066719 Lilly USA, LLC $14.41 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147320780 Mylan Specialty L.P. $26.86 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.